These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 31029281

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New drugs in Takayasu arteritis, role of tocilizumab.
    Martín Guillén S, Álvarez de Cienfuegos A, Hurtado García R.
    Reumatol Clin; 2016; 12(6):358-359. PubMed ID: 27052679
    [No Abstract] [Full Text] [Related]

  • 6. Successful tocilizumab treatment in a child with refractory Takayasu arteritis.
    Bravo Mancheño B, Perin F, Guez Vázquez Del Rey Mdel M, García Sánchez A, Alcázar Romero PP.
    Pediatrics; 2012 Dec; 130(6):e1720-4. PubMed ID: 23147976
    [Abstract] [Full Text] [Related]

  • 7. Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis.
    Goel R, Danda D, Kumar S, Joseph G.
    Int J Rheum Dis; 2013 Dec; 16(6):754-61. PubMed ID: 24382284
    [Abstract] [Full Text] [Related]

  • 8. Giant aortic aneurysm in a child with Takayasu arteritis.
    Halaweish I, Patel H, Si MS.
    Cardiol Young; 2016 Mar; 26(3):593-5. PubMed ID: 26365418
    [Abstract] [Full Text] [Related]

  • 9. Biotherapies in large vessel vasculitis.
    Ferfar Y, Mirault T, Desbois AC, Comarmond C, Messas E, Savey L, Domont F, Cacoub P, Saadoun D.
    Autoimmun Rev; 2016 Jun; 15(6):544-51. PubMed ID: 26883459
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody.
    Nishimoto N, Nakahara H, Yoshio-Hoshino N, Mima T.
    Arthritis Rheum; 2008 Apr; 58(4):1197-200. PubMed ID: 18383395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tocilizumab: a new therapy for large vessel vasculitis.
    Al-Homood IA.
    Clin Exp Med; 2014 Nov; 14(4):355-60. PubMed ID: 23949338
    [Abstract] [Full Text] [Related]

  • 14. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
    Vinicki JP, García-Vicuña R, Arredondo M, López-Bote JP, García-Vadillo JA, Castañeda S, Álvaro-Gracia JM.
    Reumatol Clin; 2017 Nov; 13(4):210-213. PubMed ID: 27499427
    [Abstract] [Full Text] [Related]

  • 15. Tocilizumab and refractory Takayasu disease: Four case reports and systematic review.
    Decker P, Olivier P, Risse J, Zuily S, Wahl D.
    Autoimmun Rev; 2018 Apr; 17(4):353-360. PubMed ID: 29427826
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Takayasu arteritis and NYHA III/IV idiopathic cardiomiopathy: tocilizumab proves effective and safe.
    Schiavon F, Cuffaro S, Ometto F, Mojoli M, Ramonda R.
    Joint Bone Spine; 2014 May; 81(3):278-9. PubMed ID: 24388783
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Acute rupture of an abdominal aortic aneurysm revealing Takayasu arteritis].
    Mleyhi S, Ghédira F, Ziadi J, Gara Ali B, Ben Gorbel I, Kaouel K, Ben Mrad M, Denguir R, Kalfat T, Khayati A.
    J Mal Vasc; 2013 Dec; 38(6):373-6. PubMed ID: 24210747
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.